...
首页> 外文期刊>European journal of cancer care >Acute interstitial pneumonitis during chemotherapy for haematological malignancy.
【24h】

Acute interstitial pneumonitis during chemotherapy for haematological malignancy.

机译:血液系统恶性肿瘤化疗期间的急性间质性肺炎。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

NAKASE K., TSUJI K., NAGAYA S., TAMAKI S., TANIGAWA M., IKEDA T., MIYANISHI E. & SHIKU H. (2005) European Journal of Cancer Care Acute interstitial pneumonitis during chemotherapy for haematological malignancy Fourteen adult patients with haematological malignancies (eight non-Hodgkin's lymphoma, one multiple myeloma, one chronic lymphocytic leukaemia, two acute lymphoblastic leukaemia and two acute myeloid leukaemia) developed acute interstitial pneumonitis (IP) during the course of chemotherapy. All patients manifested high fever over 38 degrees C, bilateral diffuse pulmonary interstitial infiltrates in the chest radiograph and severe hypoxia without hypercapnia in the arterial blood gas analysis. Pathogenic microorganisms were not detected in repeated examinations in any patient. Chemotherapy given included various anti-neoplastic drugs. Five patients had received granulocyte colony-stimulating factor (G-CSF) for chemotherapy-induced leucopenia. The onset was associated with an increase of leucocytes in 10 patients. All patients were treated with high dose steroid hormone and broad spectrum antibiotics with or without anti-fungal agents, and three required mechanical ventilation. Eleven patients quickly recovered from these situations, whereas three died. Autopsies were done in two patients and disclosed pneumocystis carinii (PC) pneumonitis in one and non-specific pulmonary congestive oedema and fibrosis in the other. In conclusion, IP of unknown cause could develop in patients with various haematological malignancies especially at the recovery phase of chemotherapy-induced leucopenia irrespective of the previous G-CSF administration. High dose steroid hormone should be used as therapy for such patients as soon as possible after exclusion of an infective aetiology.
机译:Nakaase K.,TSUJI K.,NAGAYA S.,TAMAKI S.,TANIGAWA M.,IKEDA T.,MIYANISHI E.和SHIKU H.(2005年)欧洲癌症护理杂志血液学恶性肿瘤化疗期间的急性间质性肺炎14位成人患者血液系统恶性肿瘤(八例非霍奇金淋巴瘤,一例多发性骨髓瘤,一例慢性淋巴细胞性白血病,两例急性淋巴细胞白血病和两例急性髓样白血病)在化疗过程中发展为急性间质性肺炎(IP)。所有患者均表现出38摄氏度以上的高烧,胸部X线片显示双侧弥漫性肺间质浸润,动脉血气分析显示严重低氧而无高碳酸血症。在任何患者的重复检查中均未检出致病微生物。所给予的化学疗法包括各种抗肿瘤药物。五例患者接受了化疗引起的白细胞减少症的粒细胞集落刺激因子(G-CSF)。 10例患者的发作与白细胞增加有关。所有患者均接受高剂量类固醇激素和广谱抗生素治疗,有无抗真菌药,其中三例需要机械通气。 11名患者从这些情况中迅速康复,而3名死亡。两名患者进行了尸检,其中一名患者患有卡氏肺孢子虫(PC)肺炎,另一名患者患有非特异性肺充血水肿和纤维化。综上所述,无论是先前的G-CSF给药方式,还是各种血液系统恶性肿瘤患者,尤其是在化疗引起的白细胞减少症的恢复阶段,都可能出现未知原因的IP。在排除感染病因后,应尽快使用高剂量类固醇激素作为此类患者的治疗方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号